The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 
MeSH Review

Therapeutic Human Experimentation

 
 
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.
 

Disease relevance of Therapeutic Human Experimentation

 

High impact information on Therapeutic Human Experimentation

 

Associations of Therapeutic Human Experimentation with chemical compounds

 

Gene context of Therapeutic Human Experimentation

  • In addition to antimicrobial therapy, modifications of macrophage function by IFN-gamma and blockade of TNF are attractive areas for therapeutic research [11].
  • Combining immunomodulatory agents with different mechanisms of action that promote synergistic or additive effects represents an important objective in MS therapeutic research [12].
  • Characterization of these receptors and their functions has led to an understanding of the role that ANG II plays in the body and has opened new avenues for therapeutic research [13].

References

  1. Chemical induction of brain tumors in rats by nitrosoureas: molecular biology and neuropathology. Bilzer, T., Reifenberger, G., Wechsler, W. Neurotoxicology and teratology. (1989) [Pubmed]
  2. Liver resection after irinotecan, 5-fluorouracil, and folinic acid for patients with unresectable colorectal liver metastases: a multicenter phase II study by the Cancer Therapeutic Research Group. Ho, W.M., Ma, B., Mok, T., Yeo, W., Lai, P., Lim, R., Koh, J., Wong, Y.Y., King, A., Leow, C.K., Chan, A.T. Med. Oncol. (2005) [Pubmed]
  3. Hematopoietic growth factors and the future of therapeutic research on acute myeloid leukemia. Schiffer, C.A. N. Engl. J. Med. (2003) [Pubmed]
  4. delta 9-Tetrahydrocannabinol and therapeutic research legislation for cancer patients. Treffert, D.A., Joranson, D.E. JAMA (1983) [Pubmed]
  5. L651582: a novel antiproliferative and antimetastasis agent. Kohn, E.C., Liotta, L.A. J. Natl. Cancer Inst. (1990) [Pubmed]
  6. In vivo selection of combinatorial libraries and designed affinity maturation of polydactyl zinc finger transcription factors for ICAM-1 provides new insights into gene regulation. Magnenat, L., Blancafort, P., Barbas, C.F. J. Mol. Biol. (2004) [Pubmed]
  7. Therapeutic research in untreated acute promyelocytic leukemia. Estey, E. Leukemia (2005) [Pubmed]
  8. Nedocromil sodium versus theophylline in the treatment of reversible obstructive airway disease. Crimi, E., Orefice, U., De Benedetto, F., Grassi, V., Brusasco, V. Ann. Allergy Asthma Immunol. (1995) [Pubmed]
  9. Intramural therapeutic research at the National Cancer Institute, Department of Medicine: 1955-1965. Frei, E. Cancer treatment reports. (1984) [Pubmed]
  10. Spherons as a drug target in Alzheimer's disease. Averback, P. Drug News Perspect. (1998) [Pubmed]
  11. The role of infectious agents in pulmonary and systemic vascular disease. Egermayer, P. Expert opinion on pharmacotherapy. (2001) [Pubmed]
  12. Combination therapy for multiple sclerosis: the treatment strategy of the future? Weinstock-Guttman, B., Bakshi, R. CNS drugs. (2004) [Pubmed]
  13. Blood pressure lowering and renin-angiotensin system blockade. Unger, T. Journal of hypertension. Supplement : official journal of the International Society of Hypertension. (2003) [Pubmed]
 
WikiGenes - Universities